A role for serine proteases in mediating phorbol ester-induced differentiation of HL-60 cells

Experimental Cell Research

Volumn 256, Issue 1, 2000, Pages 264-271

  Bestilny, Leslie J ^a   Riabowol, Karl T ^a  

^a Health Sciences Centre Calgary   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

4 (2 AMINOETHYL)BENZENESULFONYL FLUORIDE; CD11B ANTIGEN; DNA; MESSENGER RNA; PHORBOL 13 ACETATE 12 MYRISTATE; PHORBOL ESTER; PROTEINASE INHIBITOR; SERINE PROTEINASE; TOSYLLYSYL CHLOROMETHYL KETONE; TOSYLPHENYLALANYL CHLOROMETHYL KETONE; TRANSCRIPTION FACTOR;

ARTICLE; CELL CYCLE; CELL DIFFERENTIATION; CELL MATURATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION;

EID: 0034630465     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.2000.4821     Document Type: Article

References (30)

1. Collins, S. J. The HL-60 promyelocytic leukemia cell line: Proliferation, differentiation, and cellular oncogene expression, Blood, 70.
2. Nguyen H. Q., Hoffman-Liebermann B., Liebermann D. A. The zinc finger transcription factor Egr-1 is essential for and restricts differentiation along the macrophage lineage. Cell. 72:1993;197-209.
3. Fibach E., Treves A., Kidron M., Mayer M. Induction of differentiation in human myeloid leukemic cells by proteolytic enzymes. J. Cell. Physiol. 123:1985;228-234.
4. Fibach E., Kidron M., Nachshon I., Mayer M. Phorbol ester-induced adhesion of murine erythroleukemia cells: Possible involvement of cellular proteases. Carcinogenesis. 4:1983;1395-1399.
5. Klemes Y., Kidron M., Mayer M., Fibach E. Inhibition of phorbol-ester-induced adhesion of differentiating human myeloid leukemic cells by pentamidine-isethionate. Differentiation. 27:1984;141-145.
6. Ackerman J. J., Duerre J. A. Long-term culturing of TPA-induced differentiated HL-60 cells results in increased levels of lytic enzymes. Exp. Cell Res. 183:1989;353-360.
7. Bestilny L. J., Brown C. B., Miura Y., Robertson L. D., Riabowol K. T. Selective inhibition of telomerase activity during terminal differentiation of immortal cell lines. Cancer Res. 56:1996;3796-3802.
8. Chomczynski P., Sacchi N. Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chlorophorm extraction. Anal. Biochem. 162:1987;156.
9. Wong H., Anderson W. D., Riabowol K. T. Monitoring mRNA expression by polymerase chain reaction: The "primer-dropping" method. Anal. Biochem. 223:1994;251-258.
10. Sokoloski J. A., Sartorelli A. C., Rosen C. A., Narayanan R. Antisense oligonucleotides to the p65 subunit of NF-kappa B block CD11b expression and alter adhesion properties of differentiated HL-60 granulocytes. Blood. 15:1993;625-632.
11. Nakabo N., Pabst M. Lysis of leukemic cells by human macrophages: Inhibition by 4-(2-aminoethyl)-benzenesulfonyl fluoride (AEBSF), a serine protease inhibitor. J. Leukocyte Biol. 60:1996;328-336.
12. Rosmarin A. G., Weil S. C., Rosner G. L., Griffin J. D., Arnaout M. A., Tenen D. G. Differential expression of CD11b/CD18 (Mo1) and myeloperoxidase genes during myeloid differentiation. Blood. 73:1989;131-136.
13. Hickstein D. D., Smith A., Fisher W., Beatty P. G., Schwartz B. R., Harlan J. M., Root R. K., Locksley R. M. Expression of leukocyte adherence-related glycoproteins during differentiation of HL-60 promyelocytic leukemia cells. J. Immunol. 138:1987;513-519.
14. Hickstein D. D., Baker D. M., Gollahon K. A., Back A. L. Identification of the promoter of the myelomonocytic leukocyte integrin CD11b. Proc. Natl. Acad. Sci. USA. 89:1992;2105-2109.
15. Jones D. H., Anderson D. C., Burr B. L., Rudloff H. E., Smith C. W., Krater S. S., Schmalstieg F. C. Quantitation of intracellular Mac-1 (CD11b/CD18) pools in human neutrophils. J. Leukocyte Biol. 44:1988;535-544.
16. Solary E., Bertrand R., Pommier Y. Apoptosis of human leukemic HL-60 cells induced to differentiate by phorbol ester treatment. Leukemia. 8:1994;792-797.
17. Mintz G. R. An irreversible serine protease inhibitor. Biopharmacology. 6:1993;34-38.
18. Powers J. C., Harper J. W. Proteinase Inhibitors. 1986;Elsevier Science, New York. p. 55.
19. Kidron M., Nachshon I., Mayer M., Fibach E. Plasminogen activator activity in differentiating leukemia cells. FEBS Lett. 177:1984;66-70.
20. Blenis J., Grammer T. C. The serine proteinase inhibitors, tosylphenylalanine chloromethylketone and tosyllysine chloromethylketone, potently inhibit pp70s6k activation. J. Biol. Chem. 271:1996;23650-23652.
21. Bruno S., Del Bino G., Lassota P., Giaretti W., Darzynkiewicz Z. Inhibitors of proteases prevent endonucleolysis accompanying apoptotic death of HL-60 leukemic cells and normal thymocytes. Leukemia. 6:1992;1113-1120.
22. Brandeis M., Hunt T. The proteolysis of mitotic cyclins in mammalian cells persists from the end of mitosis until the onset of S phase. EMBO J. 15:1996;5280-5289.
23. Finco T. S., Beg A. A., Baldwin A. S. Jr. Inducible phosphorylation of IkBa is not sufficient for its dissociation from NfkB and is inhibited by protease inhibitors. Proc. Natl. Acad. Sci. USA. 91:1994;11884-11888.
24. Solomon D. H., O'Brian C. A., Weinstein I. B. N-α-tosyl-l-lysine chloromethylketone and N-α-tosyl-l-phenylalanine chloromethylketone inhibit protein kinase C. FEBS Lett. 190:1985;342-344.
25. Lotem J., Sachs L. Differential suppression by protease inhibitors and cytokines of apoptosis induced by wild-type p53 and cytotoxic agents. Proc. Natl. Acad. Sci. USA. 93:1996;12507-12512.
26. Yoshida A., Pourquier P., Pommier Y. Purification and characterization of a Mg2+-dependent endonuclease (AN34) from etoposide-treated human leukemia HL-60 cells undergoing apoptosis. Cancer Res. 58:1998;2576-2582.
27. Rovera G., Santoli D., Damsky C. Human promyelocytic leukemia cells in culture differentiate into macrophage-like cells when treated with a phorbol diester. Proc. Natl. Acad. Sci. USA. 76:1979;2779-2783.
28. Nakamura H., Oda T., Hamada K., Hirano T., Shimizu N., Utiyama H. Survival by Mac-1-mediated adherence and anoikis in phorbol ester-treated HL-60 cells. J. Biol. Chem. 273:1998;15345-15351.
29. Laouar A., Bauvois B. Characterization and modulation of cell surface proteases on human myeloblastic (HL-60) cells and comparison to normal myeloid cells. Immunol. Lett. 34:1992;257-265.
30. Oshima G., Yamada M. Preferential localisation of elastase in cytosol of human myeloid leukemia HL-60 cells. Biol. Chem. Hoppe Seyler. 372:1991;947-953.